Keyphrases
4-dione
26%
Aldehyde Dehydrogenase 2 (ALDH2)
80%
ALDH1A3
9%
ALDH3A1
9%
Anticancer Agents
12%
Benzimidazole Derivatives
26%
Bromodomain
10%
Bromodomain-containing Protein 4 (BRD4)
80%
Cancer Cells
20%
Cancer Drug Discovery
26%
Chimera
26%
Core Structure
17%
Dione
26%
DNA Damage Response
26%
Drug Discovery
53%
Drug Resistance
15%
Effector Proteins
13%
Epigenetic Therapy
26%
Erasers
26%
Genome Replication
26%
Glucose Consumption
53%
HepG2 Cells
9%
High Selectivity
9%
High-risk Human Papillomavirus (HR-HPV)
26%
Human Disease
10%
IC50 Value
9%
In Cancer
13%
Induced Proximity
26%
Inflammatory Bowel Disease
26%
Intrinsically Disordered Region
26%
Non-genetic
26%
Novel Anticancer Agent
26%
NSD2
26%
Nuclear Receptor
26%
Obesity Diabetes
12%
ONC201
26%
Oxidative Aromatization
26%
Potential Therapeutic Strategies
26%
Proteolysis Targeting chimera (PROTAC)
24%
Pyrido
26%
Pyridopyrimidine
26%
Pyrimidine-2
26%
Pyrimidine-2,4(1H,3H)-dione
26%
Pyrimidine-2,4-dione
30%
Recent Advances
15%
Receptor Binding
26%
Response Factor
26%
SET Protein
26%
Small Molecule Inhibitors
10%
Small Molecules
11%
Pharmacology, Toxicology and Pharmaceutical Science
Activating Transcription Factor 4
13%
Aldehyde Dehydrogenase
80%
Anticarcinogen
26%
Benzimidazole Derivative
26%
Cardiovascular Disease
5%
Caspase
6%
Cell Nucleus Receptor
26%
Chemotherapy
10%
Clinical Trial
32%
Diabetic Obesity
5%
Disease
91%
Disease Exacerbation
8%
Dizziness
5%
Drug Development
13%
Drug Discovery
80%
Drug Resistance
13%
Histone
5%
Histone H3
13%
Human Immunodeficiency Virus Infection
5%
IC50
12%
Infection
16%
Inflammation
31%
Inflammatory Bowel Disease
26%
Ligase
6%
Lysine
13%
Malignant Neoplasm
100%
Metabolic Disorder
9%
Metformin
5%
Nausea
5%
Proteasome
6%
Protein Ligand
6%
S-Adenosyl Methionine
13%
Side Effect
13%
Structure Activity Relationship
13%
Ubiquitin
6%
Ubiquitin Protein Ligase E3
6%
